ArticleMaterials today. Bio2026

Microfluidic-based biomimetic mitochondrial nanocomposite for targeted immunotherapy of rheumatoid arthritis via mitochondrial transplantation.

Nengjie Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.